Anticholinesterase Inhibition, Drug-Likeness Assessment, and Molecular Docking Evaluation of Milk Protein-Derived Opioid Peptides for the Control of Alzheimer’s Disease
Ji, D.; Ma, J.; Dai, J.; Xu, M.; Harris, P.W.R.; Brimble, M.A.; Agyei, D. Anticholinesterase Inhibition, Drug-Likeness Assessment, and Molecular Docking Evaluation of Milk Protein-Derived Opioid Peptides for the Control of Alzheimer’s Disease. Dairy 2022, 3, 422-437. https://doi.org/10.3390/dairy3030032
Ji D, Ma J, Dai J, Xu M, Harris PWR, Brimble MA, Agyei D. Anticholinesterase Inhibition, Drug-Likeness Assessment, and Molecular Docking Evaluation of Milk Protein-Derived Opioid Peptides for the Control of Alzheimer’s Disease. Dairy. 2022; 3(3):422-437. https://doi.org/10.3390/dairy3030032
Chicago/Turabian StyleJi, Dawei, Jingying Ma, Junyi Dai, Min Xu, Paul W.R. Harris, Margaret A. Brimble, and Dominic Agyei. 2022. "Anticholinesterase Inhibition, Drug-Likeness Assessment, and Molecular Docking Evaluation of Milk Protein-Derived Opioid Peptides for the Control of Alzheimer’s Disease" Dairy 3, no. 3: 422-437. https://doi.org/10.3390/dairy3030032